Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,342 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Relapsed primary central nervous system lymphoma treated with CD19 chimeric antigen receptor T-cell therapy and allogeneic hematopoietic stem cell transplantation].
Fujii F, Terao T, Nishimori H, Fujii K, Matsuo T, Yoshino T, Ueda H, Oyama T, Matsumura A, Kondo K, Matsubara C, Fujiwara K, Seike K, Fujiwara H, Asada N, Ennishi D, Fujii K, Fujii N, Matsuoka KI, Maeda Y. Fujii F, et al. Among authors: kondo k. Rinsho Ketsueki. 2024;65(7):622-627. doi: 10.11406/rinketsu.65.622. Rinsho Ketsueki. 2024. PMID: 39098011 Japanese.
Negative Prognostic Impact of High-Dose or Long-Term Corticosteroid Use in Patients with Relapsed or Refractory B-Cell Lymphoma Who Received Tisagenlecleucel.
Terao T, Kitamura W, Fujii N, Asada N, Kamoi C, Fujiwara K, Kondo K, Matsubara C, Hayashino K, Seike K, Fujiwara H, Ennishi D, Nishimori H, Fujii K, Matsuoka KI, Maeda Y. Terao T, et al. Among authors: kondo k. Transplant Cell Ther. 2023 Sep;29(9):573.e1-573.e8. doi: 10.1016/j.jtct.2023.06.018. Epub 2023 Jul 1. Transplant Cell Ther. 2023. PMID: 37394114 Free article.
Chimeric antigen receptor T-cell therapy after COVID-19 in refractory high-grade B-cell lymphoma.
Hayashino K, Seike K, Fujiwara K, Kondo K, Matsubara C, Terao T, Kitamura W, Kamoi C, Fujiwara H, Asada N, Nishimori H, Ennishi D, Fujii K, Fujii N, Matsuoka KI, Maeda Y. Hayashino K, et al. Among authors: kondo k. Int J Hematol. 2024 Apr;119(4):459-464. doi: 10.1007/s12185-024-03711-5. Epub 2024 Feb 13. Int J Hematol. 2024. PMID: 38349446 Free PMC article.
Early initiation of low-dose gilteritinib maintenance improves posttransplant outcomes in patients with R/R FLT3mut AML.
Terao T, Matsuoka KI, Ueda H, Matsumura A, Matsubara C, Kondo K, Kondo T, Fujiwara H, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Maeda Y. Terao T, et al. Among authors: kondo k, kondo t. Blood Adv. 2023 Mar 14;7(5):681-686. doi: 10.1182/bloodadvances.2022008991. Blood Adv. 2023. PMID: 36583677 Free PMC article. No abstract available.
4,342 results